Skip to main content
logo
Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
3.690
+0.010 (0.27%)
Oct 2, 2026, 4:00 PM EDT - Market closed

Fulcrum Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
282746254417379717
Market Cap Growth
-44.21%194.31%-39.25%10.13%-47.15%124.42%
Enterprise Value
-325525172171477
Last Close Price
3.6911.314.706.757.2817.69

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
--3.17148.7759.7537.41
PB Ratio
0.912.141.041.771.913.39
P/TBV Ratio
0.912.141.041.771.913.39

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
--0.0761.2126.9924.87

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.020.020.040.050.07-
Net Debt / Equity Ratio
-1.01-0.99-0.96-0.96-0.95-1.03
Net Debt / EBITDA Ratio
3.674.1512.742.081.732.78
Net Debt / FCF Ratio
4.745.7393.112.461.912.72
Asset Turnover
--0.310.010.030.11
Quick Ratio
31.1627.0822.1317.4412.2011.58
Current Ratio
31.3527.4022.6317.7112.4111.77
Return on Equity (ROE)
-32.38%-25.30%-4.07%-44.84%-53.53%-52.72%
Return on Assets (ROA)
-19.59%-16.90%-4.78%-28.56%-30.36%-27.79%
Return on Capital Employed (ROCE)
-27.60%-24.00%-7.90%-45.40%-53.40%-37.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-30.19%-10.04%-3.84%-23.33%-28.99%-11.28%
FCF Yield
-23.49%-8.09%-0.98%-21.92%-26.13%-11.19%
Buyback Yield / Dilution
-12.92%-2.21%-1.10%-36.27%-27.23%-39.47%
SEC Filings: 10-K · 10-Q